Compare NMG & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NMG | OFIX |
|---|---|---|
| Founded | 2011 | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 414.7M | 481.0M |
| IPO Year | 2015 | 1998 |
| Metric | NMG | OFIX |
|---|---|---|
| Price | $1.30 | $12.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $5.75 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 520.0K | 319.4K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $1.26 | $8.85 |
| 52 Week High | $6.06 | $16.99 |
| Indicator | NMG | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 37.81 | 62.07 |
| Support Level | $1.26 | $11.02 |
| Resistance Level | $1.67 | $12.40 |
| Average True Range (ATR) | 0.08 | 0.53 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 18.33 | 85.25 |
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.